Mar 14
|
INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participants
|
Mar 14
|
AstraZeneca director says AI must be a “thought partner” in drug discovery
|
Mar 14
|
AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer
|
Mar 13
|
AstraZeneca Stock Nears Buy Point After Long Run In Declining Market
|
Mar 13
|
Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?
|
Mar 12
|
Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
|
Mar 12
|
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
|
Mar 11
|
IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe
|
Mar 10
|
AstraZeneca and Ionis win EU approval for ATTR polyneuropathy
|
Mar 10
|
AstraZeneca reports positive outcomes from trial of Imfinzi
|
Feb 24
|
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
|
Feb 23
|
AstraZeneca PLC (AZN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|
Feb 22
|
3 Magnificent Growth Stocks to Buy Right Now
|
Feb 20
|
AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds
|
Feb 20
|
FibroGen sells China unit to AstraZeneca for $160m
|
Feb 20
|
AstraZeneca Rises Almost 9% in a Month: How to Play the Stock
|
Feb 20
|
Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus
|
Feb 20
|
FibroGen to Sell China Unit to AstraZeneca for $160 Million
|
Feb 20
|
Here’s Why AstraZeneca PLC (AZN) Traded Lower in Q4
|
Feb 20
|
AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal
|